Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Treatment and Prevention of Recurrent Clostridium difficile Infection with Functionalized Bovine Antibody-Enriched Whey in a Hamster Primary Infection Model.

Heidebrecht HJ, Weiss WJ, Pulse M, Lange A, Gisch K, Kliem H, Mann S, Pfaffl MW, Kulozik U, von Eichel-Streiber C.

Toxins (Basel). 2019 Feb 6;11(2). pii: E98. doi: 10.3390/toxins11020098.

2.

Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors.

von Eichel-Streiber A, Paik W, Knight K, Gisch K, Nadjafi K, Decker C, Bosnjak O, Cheknis A, Johnson S, von Eichel-Streiber C.

Anaerobe. 2016 Oct;41:91-103. doi: 10.1016/j.anaerobe.2016.07.001. Epub 2016 Jul 15.

PMID:
27427464
3.

Expression of sperm-specific protamines impairs bacterial and eukaryotic cell proliferation.

Günther K, Paradowska-Dogan A, Bärmann B, Klein H, von Eichel-Streiber C, Hartley R, Weidner W, Behr R, Steger K.

Histochem Cell Biol. 2015 Jun;143(6):599-609. doi: 10.1007/s00418-015-1309-3. Epub 2015 Feb 4.

PMID:
25649960
4.

[Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics].

Jansen A, Kleinkauf N, Weiss B, Zaiss NH, Witte W, Bornhofen B, Kist M, von Eichel-Streiber C, Neumann M, Michels H, Eckmanns T.

Z Gastroenterol. 2010 Sep;48(9):1120-5. doi: 10.1055/s-0029-1245269. Epub 2010 Sep 13. German.

PMID:
20839161
5.

Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS.

Albesa-Jové D, Bertrand T, Carpenter EP, Swain GV, Lim J, Zhang J, Haire LF, Vasisht N, Braun V, Lange A, von Eichel-Streiber C, Svergun DI, Fairweather NF, Brown KA.

J Mol Biol. 2010 Mar 12;396(5):1260-70. doi: 10.1016/j.jmb.2010.01.012. Epub 2010 Jan 11.

PMID:
20070948
6.

Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany.

Borgmann S, Kist M, Jakobiak T, Reil M, Scholz E, von Eichel-Streiber C, Gruber H, Brazier JS, Schulte B.

Euro Surveill. 2008 Dec 4;13(49). pii: 19057.

7.

Expression and prognostic relevance of annexin A3 in prostate cancer.

Köllermann J, Schlomm T, Bang H, Schwall GP, von Eichel-Streiber C, Simon R, Schostak M, Huland H, Berg W, Sauter G, Klocker H, Schrattenholz A.

Eur Urol. 2008 Dec;54(6):1314-23. doi: 10.1016/j.eururo.2008.01.001. Epub 2008 Jan 16.

PMID:
18222597
8.

Autocatalytic cleavage of Clostridium difficile toxin B.

Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, Schrattenholz A, Schild H, von Eichel-Streiber C.

Nature. 2007 Mar 22;446(7134):415-9. Epub 2007 Mar 4.

PMID:
17334356
9.

The IStron CdISt1 of Clostridium difficile: molecular symbiosis of a group I intron and an insertion element.

Hasselmayer O, Nitsche C, Braun V, von Eichel-Streiber C.

Anaerobe. 2004 Apr;10(2):85-92.

PMID:
16701504
10.

Revised nomenclature of Clostridium difficile toxins and associated genes.

Rupnik M, Dupuy B, Fairweather NF, Gerding DN, Johnson S, Just I, Lyerly DM, Popoff MR, Rood JI, Sonenshein AL, Thelestam M, Wren BW, Wilkins TD, von Eichel-Streiber C.

J Med Microbiol. 2005 Feb;54(Pt 2):113-7.

PMID:
15673503
11.

Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells.

Rupnik M, Pabst S, Rupnik M, von Eichel-Streiber C, Urlaub H, Söling HD.

Microbiology. 2005 Jan;151(Pt 1):199-208.

PMID:
15632438
12.

Rac1 and PAK1 are upstream of IKK-epsilon and TBK-1 in the viral activation of interferon regulatory factor-3.

Ehrhardt C, Kardinal C, Wurzer WJ, Wolff T, von Eichel-Streiber C, Pleschka S, Planz O, Ludwig S.

FEBS Lett. 2004 Jun 4;567(2-3):230-8.

13.

Clostridium difficile IStron CdISt1: discovery of a variant encoding two complete transposase-like proteins.

Hasselmayer O, Braun V, Nitsche C, Moos M, Rupnik M, von Eichel-Streiber C.

J Bacteriol. 2004 Apr;186(8):2508-10.

14.

Activation of NF-kappaB and IL-8 by Yersinia enterocolitica invasin protein is conferred by engagement of Rac1 and MAP kinase cascades.

Grassl GA, Kracht M, Wiedemann A, Hoffmann E, Aepfelbacher M, von Eichel-Streiber C, Bohn E, Autenrieth IB.

Cell Microbiol. 2003 Dec;5(12):957-71.

PMID:
14641180
15.

Metabotropic glutamate receptors activate phospholipase D in astrocytes through a protein kinase C-dependent and Rho-independent pathway.

Servitja JM, Masgrau R, Pardo R, Sarri E, von Eichel-Streiber C, Gutkind JS, Picatoste F.

Neuropharmacology. 2003 Feb;44(2):171-80.

PMID:
12623215
16.

GTPases of the Rho subfamily are required for Brucella abortus internalization in nonprofessional phagocytes: direct activation of Cdc42.

Guzmán-Verri C, Chaves-Olarte E, von Eichel-Streiber C, López-Goñi I, Thelestam M, Arvidson S, Gorvel JP, Moreno E.

J Biol Chem. 2001 Nov 30;276(48):44435-43. Epub 2001 Sep 28.

17.

Variant toxin B and a functional toxin A produced by Clostridium difficile C34.

Mehlig M, Moos M, Braun V, Kalt B, Mahony DE, von Eichel-Streiber C.

FEMS Microbiol Lett. 2001 May 1;198(2):171-6.

18.

[Nosocomial epidemiology and transmission of Clostridium difficile infection].

Grünewald T, Frenzel S, Decker M, Lindner B, Sultzer R, von Eichel-Streiber C, Ruf BR.

Dtsch Med Wochenschr. 2001 May 4;126(18):519-22. German.

PMID:
11381634
19.

Clostridium difficile toxins disrupt epithelial barrier function by altering membrane microdomain localization of tight junction proteins.

Nusrat A, von Eichel-Streiber C, Turner JR, Verkade P, Madara JL, Parkos CA.

Infect Immun. 2001 Mar;69(3):1329-36.

20.

Demonstration that the group II intron from the Clostridial Conjugative transposon Tn5397 undergoes splicing In vivo.

Roberts AP, Braun V, von Eichel-Streiber C, Mullany P.

J Bacteriol. 2001 Feb;183(4):1296-9.

21.

Purification and evaluation of large clostridial cytotoxins that inhibit small GTPases of Rho and Ras subfamilies.

Moos M, von Eichel-Streiber C.

Methods Enzymol. 2000;325:114-25. No abstract available.

PMID:
11036597
22.

Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II.

Hausding M, Witteck A, Rodriguez-Pascual F, von Eichel-Streiber C, Förstermann U, Kleinert H.

Br J Pharmacol. 2000 Oct;131(3):553-61.

23.

A chimeric ribozyme in clostridium difficile combines features of group I introns and insertion elements.

Braun V, Mehlig M, Moos M, Rupnik M, Kalt B, Mahony DE, von Eichel-Streiber C.

Mol Microbiol. 2000 Jun;36(6):1447-59.

25.

Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins.

Kötter K, Ji a S, von Eichel-Streiber C, Park JB, Ryu SH, Klein J.

Biochim Biophys Acta. 2000 May 31;1485(2-3):153-62.

PMID:
10832096
26.
27.

A nonsense mutation abrogates production of a functional enterotoxin A in Clostridium difficile toxinotype VIII strains of serogroups F and X.

von Eichel-Streiber C, Zec-Pirnat I, Grabnar M, Rupnik M.

FEMS Microbiol Lett. 1999 Sep 1;178(1):163-8.

28.

The actin-based motility of intracellular Listeria monocytogenes is not controlled by small GTP-binding proteins of the Rho- and Ras-subfamilies.

Ebel F, Rohde M, von Eichel-Streiber C, Wehland J, Chakraborty T.

FEMS Microbiol Lett. 1999 Jul 1;176(1):117-24.

29.

A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins.

Chaves-Olarte E, Löw P, Freer E, Norlin T, Weidmann M, von Eichel-Streiber C, Thelestam M.

J Biol Chem. 1999 Apr 16;274(16):11046-52.

30.

Regulation of phospholipase D activity in synaptosomes permeabilized with Staphylococcus aureus alpha-toxin.

Sarri E, Böckmann I, Kempter U, Valeva A, von Eichel-Streiber C, Weichel O, Klein J.

FEBS Lett. 1998 Dec 4;440(3):287-90.

31.

UDP-glucose deficiency causes hypersensitivity to the cytotoxic effect of Clostridium perfringens phospholipase C.

Flores-Díaz M, Alape-Girón A, Titball RW, Moos M, Guillouard I, Cole S, Howells AM, von Eichel-Streiber C, Florin I, Thelestam M.

J Biol Chem. 1998 Sep 18;273(38):24433-8.

32.
33.

A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmée M.

J Clin Microbiol. 1998 Aug;36(8):2240-7.

34.

Genetic rearrangements in the pathogenicity locus of Clostridium difficile strain 8864--implications for transcription, expression and enzymatic activity of toxins A and B.

Soehn F, Wagenknecht-Wiesner A, Leukel P, Kohl M, Weidmann M, von Eichel-Streiber C, Braun V.

Mol Gen Genet. 1998 May;258(3):222-32.

PMID:
9645428
35.

Rho protein inhibition blocks protein kinase C translocation and activation.

Hippenstiel S, Kratz T, Krüll M, Seybold J, von Eichel-Streiber C, Suttorp N.

Biochem Biophys Res Commun. 1998 Apr 28;245(3):830-4.

PMID:
9588200
36.

Specific inhibition of phorbol ester-stimulated phospholipase D by Clostridium sordellii lethal toxin and Clostridium difficile toxin B-1470 in HEK-293 cells. Restoration by Ral GTPases.

Schmidt M, Voss M, Thiel M, Bauer B, Grannass A, Tapp E, Cool RH, de Gunzburg J, von Eichel-Streiber C, Jakobs KH.

J Biol Chem. 1998 Mar 27;273(13):7413-22.

37.
38.

Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene.

Flores-Díaz M, Alape-Girón A, Persson B, Pollesello P, Moos M, von Eichel-Streiber C, Thelestam M, Florin I.

J Biol Chem. 1997 Sep 19;272(38):23784-91.

39.

Delineation of the catalytic domain of Clostridium difficile toxin B-10463 to an enzymatically active N-terminal 467 amino acid fragment.

Wagenknecht-Wiesner A, Weidmann M, Braun V, Leukel P, Moos M, von Eichel-Streiber C.

FEMS Microbiol Lett. 1997 Jul 1;152(1):109-16.

40.

Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile.

Hundsberger T, Braun V, Weidmann M, Leukel P, Sauerborn M, von Eichel-Streiber C.

Eur J Biochem. 1997 Mar 15;244(3):735-42.

41.

Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.

Rupnik M, Braun V, Soehn F, Janc M, Hofstetter M, Laufenberg-Feldmann R, von Eichel-Streiber C.

FEMS Microbiol Lett. 1997 Mar 15;148(2):197-202.

42.

Glucosylation of small GTP-binding Rho proteins disrupts endothelial barrier function.

Hippenstiel S, Tannert-Otto S, Vollrath N, Krüll M, Just I, Aktories K, von Eichel-Streiber C, Suttorp N.

Am J Physiol. 1997 Jan;272(1 Pt 1):L38-43.

PMID:
9038900
43.

Definition of the single integration site of the pathogenicity locus in Clostridium difficile.

Braun V, Hundsberger T, Leukel P, Sauerborn M, von Eichel-Streiber C.

Gene. 1996 Nov 28;181(1-2):29-38.

PMID:
8973304
44.

Large clostridial cytotoxins--a family of glycosyltransferases modifying small GTP-binding proteins.

von Eichel-Streiber C, Boquet P, Sauerborn M, Thelestam M.

Trends Microbiol. 1996 Oct;4(10):375-82. Review.

PMID:
8899962
45.

Restoration of Clostridium difficile toxin-B-inhibited phospholipase D by phosphatidylinositol 4,5-bisphosphate.

Schmidt M, Rümenapp U, Nehls C, Ott S, Keller J, Von Eichel-Streiber C, Jakobs KH.

Eur J Biochem. 1996 Sep 15;240(3):707-12.

46.

A role for Rho in receptor- and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B.

Schmidt M, Bienek C, Rümenapp U, Zhang C, Lümmen G, Jakobs KH, Just I, Aktories K, Moos M, von Eichel-Streiber C.

Naunyn Schmiedebergs Arch Pharmacol. 1996 Jul;354(2):87-94.

PMID:
8857584
47.

Ras, Rap, and Rac small GTP-binding proteins are targets for Clostridium sordellii lethal toxin glucosylation.

Popoff MR, Chaves-Olarte E, Lemichez E, von Eichel-Streiber C, Thelestam M, Chardin P, Cussac D, Antonny B, Chavrier P, Flatau G, Giry M, de Gunzburg J, Boquet P.

J Biol Chem. 1996 Apr 26;271(17):10217-24.

48.
49.

UDP-glucose deficiency in a mutant cell line protects against glucosyltransferase toxins from Clostridium difficile and Clostridium sordellii.

Chaves-Olarte E, Florin I, Boquet P, Popoff M, von Eichel-Streiber C, Thelestam M.

J Biol Chem. 1996 Mar 22;271(12):6925-32.

50.

Inhibition of receptor signaling to phospholipase D by Clostridium difficile toxin B. Role of Rho proteins.

Schmidt M, Rümenapp U, Bienek C, Keller J, von Eichel-Streiber C, Jakobs KH.

J Biol Chem. 1996 Feb 2;271(5):2422-6.

Supplemental Content

Loading ...
Support Center